Leerink Swann Downgrades Kythera Biopharmaceuticals To Market Perform

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analysts at Leerink Swann downgraded Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) from Outperform to Market Perform.Kythera Biopharmaceuticals shares have gained 96.46 percent over the past 52 weeks, while the S&P 500 index has surged 7.17 percent in the same period.Kythera Biopharmaceutical's shares rose 0.31 percent to close at $75.38 on Friday.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!